NM_015450.3:c.183C>G
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7
The NM_015450.3(POT1):c.183C>G(p.Leu61Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L61L) has been classified as Likely benign.
Frequency
Consequence
NM_015450.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- tumor predisposition syndrome 3Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- glioma susceptibility 9Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- thyroid gland carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- cerebroretinal microangiopathy with calcifications and cysts 3Inheritance: AR Classification: LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015450.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| POT1 | NM_015450.3 | MANE Select | c.183C>G | p.Leu61Leu | synonymous | Exon 7 of 19 | NP_056265.2 | ||
| POT1 | NR_003102.2 | n.626C>G | non_coding_transcript_exon | Exon 7 of 20 | |||||
| POT1 | NR_003103.2 | n.626C>G | non_coding_transcript_exon | Exon 7 of 18 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| POT1 | ENST00000357628.8 | TSL:2 MANE Select | c.183C>G | p.Leu61Leu | synonymous | Exon 7 of 19 | ENSP00000350249.3 | ||
| POT1 | ENST00000607932.5 | TSL:1 | n.183C>G | non_coding_transcript_exon | Exon 3 of 14 | ENSP00000476506.1 | |||
| POT1 | ENST00000608057.5 | TSL:1 | n.183C>G | non_coding_transcript_exon | Exon 3 of 16 | ENSP00000476371.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000401 AC: 1AN: 249448 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458246Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 725532 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Tumor predisposition syndrome 3 Benign:1
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at